Evidence map›Paper›PMID 41232460›Full record

ArticleSeminars in arthritis and rheumatism2025

Frailty carries an increased risk of death in rheumatoid arthritis.

Sayuli A Bhide, Punyasha Roul, Bryant R England, Hannah F Brubeck, Grant W Cannon, Namrata Singh, Courtney Loecker, Gary Kunkel, Ted R Mikuls, Dolores M Shoback and 6 more

Abstract read
In one paragraph

Article in Seminars in arthritis and rheumatism, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Sayuli A BhideVA Puget Sound Health Care System, Seattle, WA, USA; University of Washington, Seattle, WA, USA.
Punyasha RoulUniversity of Nebraska Medical Center, Omaha, NE, USA.
Bryant R EnglandUniversity of Nebraska Medical Center, Omaha, NE, USA; VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA.
Hannah F BrubeckVA Puget Sound Health Care System, Seattle, WA, USA.
Grant W CannonVA Salt Lake City & University of Utah, Salt Lake, UT, USA.
Namrata SinghUniversity of Washington, Seattle, WA, USA.
Courtney LoeckerVA Nebraska-Western Iowa Health Care System, Omaha, NE, USA; University of Nebraska Medical Center, Lincoln, NE, USA.
Gary KunkelVA Salt Lake City & University of Utah, Salt Lake, UT, USA.
Ted R MikulsUniversity of Nebraska Medical Center, Omaha, NE, USA; VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA.
Dolores M ShobackEndocrine Research Unit, San Francisco VA Medical Center, San Francisco, CA, USA; University of San Francisco Department of Medicine, San Francisco, CA, USA.
Kaleb MichaudUniversity of Nebraska Medical Center, Omaha, NE, USA; VA Nebraska-Western Iowa Health Care System, Omaha, NE, USA; Forward Databank, Wichita, KS, USA.
Patricia P KatzUniversity of San Francisco Department of Medicine, San Francisco, CA, USA.
Jose M GarciaVA Puget Sound Health Care System, Seattle, WA, USA; University of Washington, Seattle, WA, USA; VA Puget Sound Health Care System Geriatrics Research Education and Clinical Center, Seattle, WA, USA.
Ariela R OrkabyBrigham & Women's Hospital, Harvard Medical Center, Boston, MA, USA; New England GRECC (Geriatric Research, Education, and Clinical Center) VA Boston Healthcare System, Boston, MA, USA; Division of Aging, Brigham and Women's Hospital & Harvard Medical School, Boston, MA, USA.
Joshua F BakerUniversity of Pennsylvania & Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.
Katherine D WyshamVA Puget Sound Health Care System, Seattle, WA, USA; University of Washington, Seattle, WA, USA; VA Puget Sound Health Care System Geriatrics Research Education and Clinical Center, Seattle, WA, USA. Electronic address: kwysham@uw.edu.

Funding

Tracking and Evaluation CoreU54GM115458 · NIGMS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PHILIBERT, INGRID · 2016 to 2025
$42.8M
Improving cancer-related fatigue, sexual dysfunction and quality of life in older men with cancer and androgen deficiencyR01AG061558 · NIA · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI BASARIA, SHEHZAD, DEL FABBRO, EGIDIO · 2019 to 2025
$3.4M
Improving Patient-Important Outcomes with Testosterone Replacement in Hypogonadal Men with a Prior History of CancerR01CA239208 · NCI · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI BASARIA, SHEHZAD, GARCIA, JOSE M. · 2019 to 2025
$3.3M
SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)R01CA279220 · NCI · SEATTLE INST FOR BIOMEDICAL/CLINICAL RES · PI Jose M. Garcia, Sina A Gharib · 2024 to 2026
$1.4M
Improving shared decision-making around the use of disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis and cancerK23AR079588 · NIAMS · UNIVERSITY OF WASHINGTON · PI Namrata Singh · 2022 to 2026
$821k
Impact of rheumatoid arthritis on survival in older adults with cancerR03AG082857 · NIA · UNIVERSITY OF WASHINGTON · PI SINGH, NAMRATA · 2023 to 2024
$289k
BLRD VA I01 BX002807BLRD VA I01 BX003635CSRD VA IK2 CX001800CSRD VA IK2 CX002203CSRD VA IK2 CX002351NCI NIH HHS R01 CA239208NCI NIH HHS R01 CA279220NIAMS NIH HHS K23 AR079588NIA NIH HHS R01 AG061558NIA NIH HHS R03 AG082857NIGMS NIH HHS U54 GM115458RRD VA I01 RX003644RRD VA I01 RX004770
6 · The paper itself

Abstract

backgroundFrailty is prevalent among people with rheumatoid arthritis (RA) and is a risk factor for adverse outcomes, however the association between frailty and mortality in RA is not well understood.

methodsParticipants from the Veterans Association Rheumatoid Arthritis (VARA) Registry enrolled from 1/2003 to 12/2020 were included. Frailty was measured using the VA Frailty Index (VA-FI) which categorized participants as robust, pre-frail, mildly frail, and moderate/severely frail. Multivariable Cox proportional hazard modeling evaluated the relationship between baseline frailty and mortality, adjusted for demographics, disease activity, smoking, and disease treatments.

findings2792 Veterans were included with mean age of 64.3 years. 2457 (88 %) were male and 459 (17 %) were Black. Of these, 883 (32 %) were robust, 1112 (40 %) prefrail, 520 (19 %) mildly frail, and 277 (10 %) moderately to severely frail. In total, 1283 (46 %) of participants died during the 20 years of observation. The risk of mortality increased with increasing levels of frailty - prefrail aHR 1.46 [95 % CI 1.25 - 1.69], mild frailty aHR 1.97 [95 % CI 1.66 - 2.33], moderate/severe frailty aHR 2.93 [95 % CI 2.39 - 3.59]. The VA-FI frailty domains with the highest association with mortality were morbidities and functional impairments. INTERPRETATIONS: There is a stepwise increase in mortality risk and decrease in survival time, associated with higher degrees of frailty in RA. Morbidities and functional impairments are associated with the greatest risk increase of mortality. The VA-FI may serve as an important prognostic tool in the RA population.

Indexed as

Arthritis, RheumatoidFrailtyAgedFemaleHumansMaleMiddle AgedProportional Hazards ModelsRegistriesRisk FactorsSeverity of Illness IndexUnited StatesVeteransAgingFrailtyMortalityMultimorbidityRheumatoid arthritis

Identifiers

PMID41232460
PMCPMC12671584

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.